Cargando…

Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is associated with metabolic derangements including insulin resistance, although their effects on the cardiopulmonary disease are unclear. We hypothesized that insulin resistance promotes pulmonary hypertension (PH) development and mutations in type 2 bone morph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trammell, Aaron W., Talati, Megha, Blackwell, Thomas R., Fortune, Niki L., Niswender, Kevin D., Fessel, Joshua P., Newman, John H., West, James D., Hemnes, Anna R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841889/ https://www.ncbi.nlm.nih.gov/pubmed/28704134 http://dx.doi.org/10.1086/689908

Ejemplares similares

A multifaceted investigation into molecular associations of chronic thromboembolic pulmonary hypertension pathogenesis
por: Halliday, Stephen J, et al.
Publicado: (2020)

A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific
por: Talati, Megha, et al.
Publicado: (2023)

Adverse physiologic effects of Western diet on right ventricular structure and function: role of lipid accumulation and metabolic therapy
por: Brittain, Evan L., et al.
Publicado: (2018)

Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2019)

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms
por: Meegan, Jamie E., et al.
Publicado: (2023)

Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming
por: Fessel, Joshua P., et al.
Publicado: (2012)

A process-based review of mouse models of pulmonary hypertension
por: Das, Mita, et al.
Publicado: (2012)

Oxidative injury is a common consequence of BMPR2 mutations
por: Lane, Kirk L., et al.
Publicado: (2011)

Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension
por: Brittain, Evan L., et al.
Publicado: (2020)

Using Omics to Understand and Treat Pulmonary Vascular Disease
por: Hemnes, Anna R.
Publicado: (2018)

Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
por: West, James, et al.
Publicado: (2020)

Approach to a patient with pulmonary hypertension
por: Inampudi, Chakradhari, et al.
Publicado: (2019)

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
por: West, James, et al.
Publicado: (2021)

Kidney dysfunction in patients with pulmonary arterial hypertension
por: Nickel, N.P., et al.
Publicado: (2017)

Identifying “super responders” in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2017)

Glyoxylase-1 combats dicarbonyl stress and right ventricular dysfunction in rodent pulmonary arterial hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2022)

The genetics of pulmonary arterial hypertension in the post-BMPR2 era
por: Fessel, Joshua P., et al.
Publicado: (2011)

Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
por: Hemnes, Anna R., et al.
Publicado: (2017)

l‐Carnitine therapy improves right heart dysfunction through Cpt1‐dependent fatty acid oxidation
por: Agrawal, Vineet, et al.
Publicado: (2022)

Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension
por: Karpov, Andrei A., et al.
Publicado: (2022)

Low-grade albuminuria in pulmonary arterial hypertension
por: Nickel, Nils P., et al.
Publicado: (2019)

Predictors of Diastolic-To-Wedge Gradient in Patients Evaluated for Pulmonary Hypertension
por: Brittain, Evan L., et al.
Publicado: (2013)

Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre‐ and postcapillary pulmonary hypertension
por: Babu, Gautam, et al.
Publicado: (2023)

Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension
por: Egnatchik, Robert A., et al.
Publicado: (2017)

Hemodynamic Improvement of Pulmonary Arterial Hypertension After Bariatric Surgery: Potential Role for Metabolic Regulation
por: Pugh, Meredith E., et al.
Publicado: (2013)

Effect of pulmonary hypertension on 5‐year outcome of kidney transplantation
por: Rabih, Fadi, et al.
Publicado: (2022)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
por: Caccamo, Marco, et al.
Publicado: (2023)

JNK2 regulates vascular remodeling in pulmonary hypertension
por: Das, Mita, et al.
Publicado: (2018)

CD44 and xCT: The Silver Bullet for Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension?
por: Agrawal, Vineet, et al.
Publicado: (2019)

Pulmonary Vascular Remodeling in Pulmonary Hypertension
por: Jia, Zhuangzhuang, et al.
Publicado: (2023)

Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2019)

Reduced free-living activity levels in pulmonary arterial hypertension patients
por: Halliday, Stephen J., et al.
Publicado: (2018)

Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2018)

An evidence-based knowledgebase of pulmonary arterial hypertension to identify genes and pathways relevant to pathogenesis
por: Zhao, Min, et al.
Publicado: (2014)

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
por: Sakao, Seiichiro, et al.
Publicado: (2014)

Evidence of pulmonary arterial hypertension in two patients with common variable immunodeficiency
por: Huston, Jessica, et al.
Publicado: (2020)

Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge
por: Agrawal, Vineet, et al.
Publicado: (2019)

Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility
por: Wallace, William D., et al.
Publicado: (2018)

Vorticity for the assessment of pulmonary vascular hemodynamics in pulmonary arterial hypertension
por: Honeyman, Alexander, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tpodtrpa60tgok7t14oqiqseos